✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

RPG Life Sciences Ltd.

RPGLIFE

Market Cap
₹3,601 Cr.
P/E
19.65

RPG Life Sciences Ltd.

  • RPG Life Sciences
  • Morepen Laboratories
  • Panacea Biotec
  • TJI Pharma - Small Cap
FAQs on RPG Life Sciences Ltd. Shareprice

RPG Life Sciences has given better returns compared to its competitors.
RPG Life Sciences has grown at ~26.1% over the last 7yrs while peers have grown at a median rate of 10.18%

RPG Life Sciences is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of RPG Life Sciences is 19.65, while 3 year average PE is 26.52.
Also latest EV/EBITDA of RPG Life Sciences is 25.8 while 3yr average is 15.56.

View FAQ's On Business
Growth Table
  • RPG Life Sciences Ltd.
  • Morepen Laboratories
  • Panacea Biotec
Balance Sheet
  • RPG Life Sciences Ltd.
  • Morepen Laboratories
  • Panacea Biotec
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • RPG Life Sciences Ltd.
  • Morepen Laboratories
  • Panacea Biotec
Cash Flow
  • RPG Life Sciences Ltd.
  • Morepen Laboratories
  • Panacea Biotec
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • RPG Life Sciences Ltd.
  • Morepen Laboratories
  • Panacea Biotec
Quarterly Results
  • RPG Life Sciences Ltd.
  • Morepen Laboratories
  • Panacea Biotec
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on RPG Life Sciences Ltd. Financials

Balance sheet of RPG Life Sciences is strong.
It shouldn't have solvency or liquidity issues.

The debt of RPG Life Sciences is decreasing.
Latest debt of RPG Life Sciences is -₹139.61 Crs as of Mar-25.
This is less than Mar-24 when it was -₹72.92 Crs.

Yes, profit is increasing.
The profit of RPG Life Sciences is ₹183 Crs for TTM, ₹87.66 Crs for Mar 2024 and ₹67.64 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
RPG Life Sciences latest dividend payout ratio is 30.18% and 3yr average dividend payout ratio is 30.12%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech